Skip to main content
. 2017 Jul 9;14(3):2310–2316. doi: 10.3892/etm.2017.4741

Table I.

Primers used for polymerase chain reaction.

Gene Direction Sequence
Kcna5 Forward 5-ATCACCAGCGGGTCCTCATAA-3
Reverse 5-GGAGGGTGTTGGGAAACTGC-3
Kcnd2 Forward 5-TCAGGACGCTCTGATAGTGCT-3
Reverse 5-TCTGGGTATCGTTCCAGGGTG-3
KChIP2 Forward 5-AGCGTGGAGGATGAGTTTGAAC-3
Reverse 5-TTCCCCGAAGAATCACTGACA-3
Slc9a1 Forward 5-TCATCCACCTCGGATCTTCCC-3
Reverse 5-TCCTGAGAACAGGTAGCAGTC-3
TFPI Forward 5-CAGGCGTCGGGTTACAAAAGA-3
Reverse 5-GGAACTCAGAAAGCCTTGGTAAG-3
TM Forward 5-AGTGTGCCAGTTCATAAGAATC-3
Reverse 5-GTTCTACAAAGGTTGGAAACTC-3
eNOS Forward 5-GGCAAGACAGACTACACGAC-3
Reverse 5-ATCGCCGCAGACAAACAT-3
Rac1 Forward 5-ACGGAGCTGTTGGTAAAACCT-3
Reverse 5-AGACGGTGGGGATGTACTCTC-3
GAPDH Forward AGTGGCAAAGTGGAGATT
Reverse GTGGAGTCATACTGGAACA

Kcna5, potassium voltage-gated channel subfamily A member 5; Kcnd2, potassium voltage-gated channel subfamily D member 2; KChIP2, Kv channel-interacting protein 2; Slc9a1, solute carrier family 9 member A1; TFPI, tissue factor pathway inhibitor; TM, thrombomodulin; eNOS, endothelial nitric oxide synthase; Rac1, Ras-related C3 botulinum toxin substrate 1.